R&D and Innovation Manufacturing Regulatory Expertise Customer service Quality

Scale, Quality & Precision — Built for Global Healthcare Delivery

MSN’s manufacturing ecosystem is engineered to support global healthcare with uncompromising reliability, scalability, and regulatory excellence. Spanning 17 API facilities across 500+ acres, our infrastructure enables large-volume production, rapid response to demand, and end-to-end quality control. Through robust backward integration, specialised high-containment capabilities, advanced technology, and strict safety frameworks, MSN delivers consistent value to customers worldwide.

All facilities are located within a 100 km radius of Hyderabad, enabling seamless coordination, faster decision-making, and accelerated execution.

Manufacturing Scale & Infrastructure

17

API facilities across 500+ acres

Network supports APIs across

75+

therapeutic categories

500+

API portfolio including complex and niche molecules

All sites located

2 hours

from HQ for operational agility

2400+

reactors (SS / GL / Hastelloy)

10,000+ KL

total reaction volume

1500+ MT

APIs manufactured annually

Batch sizes

from 100+ grams to 500+ kg

from 50 L to 20 KL

Reactor volumes

12

industrial-scale Prep-HPLC units

Advanced drying capabilities:

spray dryers, FBDs

Particle size milling up to

D90 < 5 microns

Backward Integration & Supply commitment

A fully self-reliant API ecosystem designed for stability and cost leadership.

Core Strengths

  • Most intermediates in-house
  • > 50% in-house KSMs
  • Minimal dependence on China
  • Guaranteed supply assurance & consistent quality
  • End-to-end control over timelines, quality, and cost

Benefits to Customers

  • Enhanced visibility and predictability
  • Stable long-term partnership potential
  • Lower supply risk and dependency

Specialized High-Containment Facilities

Infrastructure tailored for complex, potent, and sensitive molecules.

Oncology

We maintain the highest standards of quality across all operations to ensure consistent global compliance. Every step reflects our commitment to delivering safe, reliable, and robust APIs.

Prostaglandins

We ensure affordability by optimizing API life cycles with efficient, value-driven processes. Our approach creates sustainable advantages for customers and patients.

Peptides

We offer strong regulatory support that empowers our customers’ ANDA filings, approvals, and timely launches. Our expertise ensures smooth, reliable progression through global regulatory pathways.

Hormones

We are committed to delivering quick, detailed, and API-specific deficiency responses. Our customer-centric teams work with precision to resolve queries and keep development timelines on track.

Pilot Plant & Kilo Lab Excellence

Bridging development to commercial scale with unmatched speed.

  • 30 reactors
  • 5 KL reaction volume
  • Enables seamless scale-up from lab to commercia
  • Accelerates customer launches with predictable tech-transfer

Proactive Capacity Management

Always prepared for new product launches, regulatory opportunities, and surge demand.

Strategic Planning

  • 5-year demand forecasting
  • Capacity creation initiated 3 years ahead
  • Expansion cycles completed within 15–18 months

Supply Confidence

  • 25–30% surplus capacity always maintained
  • Ensures uninterrupted supply during peak or emergency demand
  • Supports long-term customer launch roadmaps